What is the latest status of the project “MS Pharma”?

The status recorded for “MS Pharma” is active.

Who are the main government, EPC, and private stakeholders for “MS Pharma”?

Taiyo maps the stakeholders of “MS Pharma”: government bodies (International Finance Corporation (IFC)).

What is the budget and commercial profile for the project “MS Pharma”?

Taiyo normalizes the budget of “MS Pharma” to USD 50000000.

Where can I verify the source and access all details for “MS Pharma”?

This Taiyo project page references International Finance Corporation (IFC) along with the original URL (https://disclosures.ifc.org/project-detail/SII/37564/ms-pharma). Taiyo standardizes official data into a consistent, searchable project profile.

MS Pharma

Sector: Water Supply and Storage • Location: Jordan

Source: International Finance Corporation (IFC)

Project

Active

MS Pharma Ventures Holdings WLL (the “Company”) is a limited liability company incorporated in the Kingdom of Bahrain, active in development, manufacturing and marketing of branded generic pharmaceuticals in Jordan, Algeria, Turkey and other MENA (Middle East and North Africa) countries. Established in 2011 as integrated international pharmaceutical company with three key operating businesses: (i)

Project Information

5 Q

The project “MS Pharma” is an infrastructure initiative in the Water Supply and Storage sector, located in Jordan. Taiyo aggregates data on it from International Finance Corporation (IFC).

Want to explore the full details? View the full report

Participants

Sponsoring Agency	Obfuscated Data
Company	Obfuscated Data

Status

Original status	active
Taiyo status	Obfuscated Data
Taiyo last update	00-00-0000
Available timestamps	00-00-0000
Available timestamp type	Obfuscated Data

Contact

Contact name	Obfuscated Data
Phone	0000000000
Email	ObfuscatedData@email.com
Address	Obfuscated Data, Obfuscated data, obfuscated data, Obfuscated data

Description

Description	MS Pharma Ventures Holdings WLL (the “Company”) is a limited liability company incorporated in the Kingdom of Bahrain, active in development, manufacturing and marketing of branded generic pharmaceuticals in Jordan, Algeria, Turkey and other MENA (Middle East and North Africa) countries. Established in 2011 as integrated international pharmaceutical company with three key operating businesses: (i) El Kendi Pharmaceutical Manufacturing Company (Algeria), (ii) United Pharmaceuticals Manufacturing (Jordan), and (iii) MS Pharma Injectibles (Jordan and Turkey). MS Pharma specializes in medication treatment for chronic diseases such as cardiovascular, central nervous system, and respiratory diseases, therapeutic classes which are experiencing high growth rates across MENA region. The Company has invited IFC to support its investment plan of up to US$150 million financing of acquisition opportunities to enter new markets and capacity expansion in its existing facilities (the “Project”).
Original sub-sector	Obfuscated
Original Currency	USD
Original budget	000000000000000
Procurement method	Obfuscated Data
Budget	000000000000000

Location

Region	Obfuscated
Country	Obfuscated
State	Obfuscated Data
County	Obfuscated
Location	Obfuscated Data, Obfuscated data, obfuscated data, Obfuscated data

Source

Source reliability	High
Data quality score	100%
Source	Obfuscated Data
URL	obfuscated_data,obfuscateddata.com

More Details

Project Type	Obfuscated Data
Article Published Date	Obfuscated Data

MS Pharma

Project Information FAQ

Project Information

More Water Supply and Storage projects in Jordan